Click for best price
Breast Cancer Therapeutic Market Size, Share 2022
This report contains market size and forecasts of Breast Cancer Therapeutic in Global, including the following market information:
- Global Breast Cancer Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Breast Cancer Therapeutic market was valued at 19310 million in 2021 and is projected to reach US$ 30750 million by 2028, at a CAGR of 6.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Phase I Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Breast Cancer Therapeutic include AstraZeneca, Eisai, Eli Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis International AG, Pfizer, Puma Biotechnology and Sanofi S.A. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Breast Cancer Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Breast Cancer Therapeutic Market Segment Percentages, by Type, 2021 (%)
- Phase I Treatment
- Phase II Treatment
- Phase III Treatment
Global Breast Cancer Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Breast Cancer Therapeutic Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Ambulatory Surgical Center
- Diagnostic Centers
Global Breast Cancer Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Breast Cancer Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Breast Cancer Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Breast Cancer Therapeutic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AstraZeneca
- Eisai
- Eli Lilly and Company
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Novartis International AG
- Pfizer
- Puma Biotechnology
- Sanofi S.A.
- Teva Pharmaceutical Industries
| Report Attributes |
Report Details |
| Report Title |
Breast Cancer Therapeutic Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Breast Cancer Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Breast Cancer Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Breast Cancer Therapeutic Overall Market Size
2.1 Global Breast Cancer Therapeutic Market Size: 2021 VS 2028
2.2 Global Breast Cancer Therapeutic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Breast Cancer Therapeutic Players in Global Market
3.2 Top Global Breast Cancer Therapeutic Companies Ranked by Revenue
3.3 Global Breast Cancer Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Breast Cancer Therapeutic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Breast Cancer Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Breast Cancer Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Breast Cancer Therapeutic Market Size Markets, 2021 & 2028
4.1.2 Phase I Treatment
4.1.3 Phase II Treatment
4.1.4 Phase III Treatment
4.2 By Type - Global Breast Cancer Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Breast Cancer Therapeutic Revenue, 2017-2022
4.2.2 By Type - Global Breast Cancer Therapeutic Revenue, 2023-2028
4.2.3 By Type - Global Breast Cancer Therapeutic Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Breast Cancer Therapeutic Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Center
5.1.4 Diagnostic Centers
5.2 By Application - Global Breast Cancer Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Breast Cancer Therapeutic Revenue, 2017-2022
5.2.2 By Application - Global Breast Cancer Therapeutic Revenue, 2023-2028
5.2.3 By Application - Global Breast Cancer Therapeutic Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Breast Cancer Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global Breast Cancer Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Breast Cancer Therapeutic Revenue, 2017-2022
6.2.2 By Region - Global Breast Cancer Therapeutic Revenue, 2023-2028
6.2.3 By Region - Global Breast Cancer Therapeutic Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Breast Cancer Therapeutic Revenue, 2017-2028
6.3.2 US Breast Cancer Therapeutic Market Size, 2017-2028
6.3.3 Canada Breast Cancer Therapeutic Market Size, 2017-2028
6.3.4 Mexico Breast Cancer Therapeutic Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Breast Cancer Therapeutic Revenue, 2017-2028
6.4.2 Germany Breast Cancer Therapeutic Market Size, 2017-2028
6.4.3 France Breast Cancer Therapeutic Market Size, 2017-2028
6.4.4 U.K. Breast Cancer Therapeutic Market Size, 2017-2028
6.4.5 Italy Breast Cancer Therapeutic Market Size, 2017-2028
6.4.6 Russia Breast Cancer Therapeutic Market Size, 2017-2028
6.4.7 Nordic Countries Breast Cancer Therapeutic Market Size, 2017-2028
6.4.8 Benelux Breast Cancer Therapeutic Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Breast Cancer Therapeutic Revenue, 2017-2028
6.5.2 China Breast Cancer Therapeutic Market Size, 2017-2028
6.5.3 Japan Breast Cancer Therapeutic Market Size, 2017-2028
6.5.4 South Korea Breast Cancer Therapeutic Market Size, 2017-2028
6.5.5 Southeast Asia Breast Cancer Therapeutic Market Size, 2017-2028
6.5.6 India Breast Cancer Therapeutic Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Breast Cancer Therapeutic Revenue, 2017-2028
6.6.2 Brazil Breast Cancer Therapeutic Market Size, 2017-2028
6.6.3 Argentina Breast Cancer Therapeutic Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Breast Cancer Therapeutic Revenue, 2017-2028
6.7.2 Turkey Breast Cancer Therapeutic Market Size, 2017-2028
6.7.3 Israel Breast Cancer Therapeutic Market Size, 2017-2028
6.7.4 Saudi Arabia Breast Cancer Therapeutic Market Size, 2017-2028
6.7.5 UAE Breast Cancer Therapeutic Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Breast Cancer Therapeutic Major Product Offerings
7.1.4 AstraZeneca Breast Cancer Therapeutic Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Eisai
7.2.1 Eisai Corporate Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Breast Cancer Therapeutic Major Product Offerings
7.2.4 Eisai Breast Cancer Therapeutic Revenue in Global Market (2017-2022)
7.2.5 Eisai Key News
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Corporate Summary
7.3.2 Eli Lilly and Company Business Overview
7.3.3 Eli Lilly and Company Breast Cancer Therapeutic Major Product Offerings
7.3.4 Eli Lilly and Company Breast Cancer Therapeutic Revenue in Global Market (2017-2022)
7.3.5 Eli Lilly and Company Key News
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Corporate Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Breast Cancer Therapeutic Major Product Offerings
7.4.4 F. Hoffmann-La Roche Breast Cancer Therapeutic Revenue in Global Market (2017-2022)
7.4.5 F. Hoffmann-La Roche Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Breast Cancer Therapeutic Major Product Offerings
7.5.4 GlaxoSmithKline Breast Cancer Therapeutic Revenue in Global Market (2017-2022)
7.5.5 GlaxoSmithKline Key News
7.6 Novartis International AG
7.6.1 Novartis International AG Corporate Summary
7.6.2 Novartis International AG Business Overview
7.6.3 Novartis International AG Breast Cancer Therapeutic Major Product Offerings
7.6.4 Novartis International AG Breast Cancer Therapeutic Revenue in Global Market (2017-2022)
7.6.5 Novartis International AG Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Breast Cancer Therapeutic Major Product Offerings
7.7.4 Pfizer Breast Cancer Therapeutic Revenue in Global Market (2017-2022)
7.7.5 Pfizer Key News
7.8 Puma Biotechnology
7.8.1 Puma Biotechnology Corporate Summary
7.8.2 Puma Biotechnology Business Overview
7.8.3 Puma Biotechnology Breast Cancer Therapeutic Major Product Offerings
7.8.4 Puma Biotechnology Breast Cancer Therapeutic Revenue in Global Market (2017-2022)
7.8.5 Puma Biotechnology Key News
7.9 Sanofi S.A.
7.9.1 Sanofi S.A. Corporate Summary
7.9.2 Sanofi S.A. Business Overview
7.9.3 Sanofi S.A. Breast Cancer Therapeutic Major Product Offerings
7.9.4 Sanofi S.A. Breast Cancer Therapeutic Revenue in Global Market (2017-2022)
7.9.5 Sanofi S.A. Key News
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Corporate Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries Breast Cancer Therapeutic Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Breast Cancer Therapeutic Revenue in Global Market (2017-2022)
7.10.5 Teva Pharmaceutical Industries Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Breast Cancer Therapeutic Market Opportunities & Trends in Global Market
Table 2. Breast Cancer Therapeutic Market Drivers in Global Market
Table 3. Breast Cancer Therapeutic Market Restraints in Global Market
Table 4. Key Players of Breast Cancer Therapeutic in Global Market
Table 5. Top Breast Cancer Therapeutic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Breast Cancer Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Breast Cancer Therapeutic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Breast Cancer Therapeutic Product Type
Table 9. List of Global Tier 1 Breast Cancer Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Breast Cancer Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Breast Cancer Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Breast Cancer Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Breast Cancer Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Breast Cancer Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Breast Cancer Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Breast Cancer Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Breast Cancer Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Breast Cancer Therapeutic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Breast Cancer Therapeutic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Breast Cancer Therapeutic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Breast Cancer Therapeutic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Breast Cancer Therapeutic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Breast Cancer Therapeutic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Breast Cancer Therapeutic Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Breast Cancer Therapeutic Product Offerings
Table 32. AstraZeneca Breast Cancer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Corporate Summary
Table 34. Eisai Breast Cancer Therapeutic Product Offerings
Table 35. Eisai Breast Cancer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly and Company Corporate Summary
Table 37. Eli Lilly and Company Breast Cancer Therapeutic Product Offerings
Table 38. Eli Lilly and Company Breast Cancer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 39. F. Hoffmann-La Roche Corporate Summary
Table 40. F. Hoffmann-La Roche Breast Cancer Therapeutic Product Offerings
Table 41. F. Hoffmann-La Roche Breast Cancer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Breast Cancer Therapeutic Product Offerings
Table 44. GlaxoSmithKline Breast Cancer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 45. Novartis International AG Corporate Summary
Table 46. Novartis International AG Breast Cancer Therapeutic Product Offerings
Table 47. Novartis International AG Breast Cancer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Breast Cancer Therapeutic Product Offerings
Table 50. Pfizer Breast Cancer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 51. Puma Biotechnology Corporate Summary
Table 52. Puma Biotechnology Breast Cancer Therapeutic Product Offerings
Table 53. Puma Biotechnology Breast Cancer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 54. Sanofi S.A. Corporate Summary
Table 55. Sanofi S.A. Breast Cancer Therapeutic Product Offerings
Table 56. Sanofi S.A. Breast Cancer Therapeutic Revenue (US$, Mn), (2017-2022)
Table 57. Teva Pharmaceutical Industries Corporate Summary
Table 58. Teva Pharmaceutical Industries Breast Cancer Therapeutic Product Offerings
Table 59. Teva Pharmaceutical Industries Breast Cancer Therapeutic Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Breast Cancer Therapeutic Segment by Type in 2021
Figure 2. Breast Cancer Therapeutic Segment by Application in 2021
Figure 3. Global Breast Cancer Therapeutic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Breast Cancer Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Breast Cancer Therapeutic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Breast Cancer Therapeutic Revenue in 2021
Figure 8. By Type - Global Breast Cancer Therapeutic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Breast Cancer Therapeutic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Breast Cancer Therapeutic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Breast Cancer Therapeutic Revenue Market Share, 2017-2028
Figure 12. US Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Breast Cancer Therapeutic Revenue Market Share, 2017-2028
Figure 16. Germany Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 17. France Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Breast Cancer Therapeutic Revenue Market Share, 2017-2028
Figure 24. China Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 28. India Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Breast Cancer Therapeutic Revenue Market Share, 2017-2028
Figure 30. Brazil Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Breast Cancer Therapeutic Revenue Market Share, 2017-2028
Figure 33. Turkey Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Breast Cancer Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Breast Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Breast Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly and Company Breast Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. F. Hoffmann-La Roche Breast Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Breast Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis International AG Breast Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Breast Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Puma Biotechnology Breast Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sanofi S.A. Breast Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Teva Pharmaceutical Industries Breast Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
